Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Vogt

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Chemosphere|August 13, 2014
Historical trends of inorganic and organic fluorine in sediments of Lake MichiganGarry Codling, Anja Vogt, Paul D Jones, et al.
Current Medical Research and Opinion|July 24, 2025
Physician and patient perspectives on the treatment of hypercholesterolaemia: a cross-sectional study to identify disconnectsAdie Viljoen, Vivian Auyeung, Holly Foot, et al.
European Heart Journal|August 31, 2016
Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trialPatrick M Moriarty, Klaus G Parhofer, Stephan P Babirak, et al.
Ebiomedicine|January 24, 2017
Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL ClearanceNicole Paulin, Yvonne Döring, Sander Kooijman, et al.
Atherosclerosis|October 2, 2018
Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh RegistryNina Schmidt, Alexander Dressel, Tanja B Grammer, et al.
Circulation|January 18, 2006
Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trialAxel Schmermund, Stephan Achenbach, Thomas Budde, et al.
Plos One|May 16, 2017
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohortKathrin Kahnert, Tanja Lucke, Rudolf M Huber, et al.
Journal of Clinical Lipidology|April 9, 2016
Pathogenic classification of LPL gene variants reported to be associated with LPL deficiencyRute Rodrigues, Marta Artieda, Diego Tejedor, et al.
European Heart Journal|May 19, 2026
Lipoprotein apheresis in the era of new lipid-lowering therapiesFrancesco Sbrana, Beatrice Dal Pino, Volker J J Schettler, et al.
Atherosclerosis Plus|July 12, 2023
The German CaRe high registry for familial hypercholesterolemia - Sex differences, treatment strategies, and target value attainmentWinfried März, Nina Schmidt, Ira An Haack, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Chemosphere|August 13, 2014
Historical trends of inorganic and organic fluorine in sediments of Lake MichiganGarry Codling, Anja Vogt, Paul D Jones, et al.
Current Medical Research and Opinion|July 24, 2025
Physician and patient perspectives on the treatment of hypercholesterolaemia: a cross-sectional study to identify disconnectsAdie Viljoen, Vivian Auyeung, Holly Foot, et al.
European Heart Journal|August 31, 2016
Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trialPatrick M Moriarty, Klaus G Parhofer, Stephan P Babirak, et al.
Ebiomedicine|January 24, 2017
Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL ClearanceNicole Paulin, Yvonne Döring, Sander Kooijman, et al.
Atherosclerosis|October 2, 2018
Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh RegistryNina Schmidt, Alexander Dressel, Tanja B Grammer, et al.
Circulation|January 18, 2006
Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trialAxel Schmermund, Stephan Achenbach, Thomas Budde, et al.
Plos One|May 16, 2017
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohortKathrin Kahnert, Tanja Lucke, Rudolf M Huber, et al.
Journal of Clinical Lipidology|April 9, 2016
Pathogenic classification of LPL gene variants reported to be associated with LPL deficiencyRute Rodrigues, Marta Artieda, Diego Tejedor, et al.
European Heart Journal|May 19, 2026
Lipoprotein apheresis in the era of new lipid-lowering therapiesFrancesco Sbrana, Beatrice Dal Pino, Volker J J Schettler, et al.
Atherosclerosis Plus|July 12, 2023
The German CaRe high registry for familial hypercholesterolemia - Sex differences, treatment strategies, and target value attainmentWinfried März, Nina Schmidt, Ira An Haack, et al.
Pageof 6